| Immunoinformatics and structural analysis for identification of immunodominant epitopes in SARS-CoV-2 as potential vaccine targets S Mukherjee, D Tworowski, R Detroja, SB Mukherjee, ... Vaccines 8 (2), 290, 2020 | 74 | 2020 |
| COVID19 Drug Repository: text-mining the literature in search of putative COVID19 therapeutics D Tworowski, A Gorohovski, S Mukherjee, G Carmi, E Levy, R Detroja, ... Nucleic acids research 49 (D1), D1113-D1121, 2021 | 44 | 2021 |
| Clinical and molecular characterization of a rare case of BNT162b2 mRNA COVID-19 vaccine-associated myositis E Magen, S Mukherjee, M Bhattacharya, R Detroja, E Merzon, I Blum, ... Vaccines 10 (7), 1135, 2022 | 38 | 2022 |
| ChiTaRS 5.0: the comprehensive database of chimeric transcripts matched with druggable fusions and 3D chromatin maps D Balamurali, A Gorohovski, R Detroja, V Palande, D Raviv-Shay, ... Nucleic acids research 48 (D1), D825-D834, 2020 | 33 | 2020 |
| Detection of gene mutations and gene–gene fusions in circulating cell‐free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis V Palande, T Siegal, R Detroja, A Gorohovski, R Glass, C Flueh, ... Molecular Oncology 16 (10), 2098-2114, 2022 | 28 | 2022 |
| Altered expression and localization of tumor suppressive E3 ubiquitin ligase SMURF2 in human prostate and breast cancer A Emanuelli, D Manikoth Ayyathan, P Koganti, PA Shah, L Apel-Sarid, ... Cancers 11 (4), 556, 2019 | 22 | 2019 |
| Computational analysis of sense-antisense chimeric transcripts reveals their potential regulatory features and the landscape of expression in human cells S Mukherjee, R Detroja, D Balamurali, E Matveishina, YA Medvedeva, ... NAR Genomics and Bioinformatics 3 (3), lqab074, 2021 | 19 | 2021 |
| The chromatin remodeler Chd1 regulates cohesin in budding yeast and humans A Boginya, R Detroja, A Matityahu, M Frenkel-Morgenstern, I Onn Scientific Reports 9 (1), 8929, 2019 | 18 | 2019 |
| Identifying hub genes associated with neoadjuvant chemotherapy resistance in breast cancer and potential drug repurposing for the development of precision medicine T Saha Detroja, R Detroja, S Mukherjee, AO Samson International Journal of Molecular Sciences 23 (20), 12628, 2022 | 9 | 2022 |
| tRNA methylation resolves codon usage bias at the limit of cell viability I Masuda, Y Yamaki, R Detroja, S Tagore, H Moore, S Maharjan, ... Cell reports 41 (4), 2022 | 8 | 2022 |
| Incipient sympatric speciation and evolution of soil bacteria revealed by metagenomic and structured non-coding RNAs analysis S Mukherjee, Z Kuang, S Ghosh, R Detroja, G Carmi, S Tripathy, ... Biology 11 (8), 1110, 2022 | 7 | 2022 |
| The landscape of novel expressed chimeric RNAs in rheumatoid arthritis R Detroja, S Mukherjee, M Frenkel-Morgenstern Cells 11 (7), 1092, 2022 | 6 | 2022 |
| ChiTaH: a fast and accurate tool for identifying known human chimeric sequences from high-throughput sequencing data R Detroja, A Gorohovski, O Giwa, G Baum, M Frenkel-Morgenstern NAR genomics and bioinformatics 3 (4), lqab112, 2021 | 6 | 2021 |
| The landscape of differential splicing and transcript alternations in severe COVID‐19 infection SB Mukherjee, S Mukherjee, R Detroja, M Frenkel‐Morgenstern The FEBS Journal 290 (12), 3128-3144, 2023 | 4 | 2023 |
| Identification of genetic subtypes in follicular lymphoma V Shelton, R Detroja, T Liu, K Isaev, A Silva, V Passerini, M Bakhtiari, ... Blood cancer journal 14 (1), 128, 2024 | 2 | 2024 |
| The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients SB Mukherjee, R Detroja, S Mukherjee, M Frenkel-Morgenstern Viruses 15 (2), 433, 2023 | 2 | 2023 |
| A liquid biopsy platform for detecting gene-gene fusions as glioma diagnostic biomarkers and drug targets V Palande, R Detroja, A Gorohovski, R Glass, C Flueh, M Kurtz, S Perez, ... bioRxiv, 2020.02. 25.963975, 2020 | 2 | 2020 |
| Draft genome sequence of the yeast Saccharomyces cerevisiae GUJ105 from Gujarat, India C Badapanda, R Detroja, A Rathore Genome Announcements 4 (6), 10.1128/genomea. 01315-16, 2016 | 1 | 2016 |
| Circulating cell-free DNA in oral squamous cell carcinoma patients allows for non-invasive prognosis and identification of structural variants, novel chimeras and oncoviruses M Bhattacharya, D Yaniv, S Pachakar, DP D’Souza, R Detroja, G Baum, ... | | 2023 |
| The applications of circulating cell-free DNA for oral squamous cell carcinoma patients as non-invasive diagnostics of structural variants, fusions and oncoviruses M Bhattacharya, D Yaniv, E Yosefof, S Tzelnick, R Detroja, DP D’Souza, ... medRxiv, 2023.11. 29.23299177, 2023 | | 2023 |
Milana Frenkel-MorgensternPrincipal Investigator, Reichman University在 runi.ac.il 的电子邮件经过验证
